EIP
ARNA

Ellis Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ellis Investment Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,250
Closed -$96K – 799
2020
Q4 		$96K Hold
1,250
– – 0.03% 286
2020
Q3 		$93K Hold
1,250
– – 0.03% 270
2020
Q2 		$78K Buy
+1,250
New +$68.8K 0.03% 290

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ellis Investment Partners's ARNA Position: Q1 2021 in Review

Ellis Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 1,250 shares — an estimated $96K sold.

Ellis Investment Partners first reported a position in ARNA in Q2 2020 and held it in 3 quarters. The position peaked at $96K in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Ellis Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Ellis Investment Partners sold 1,250 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $96K.
  • Ellis Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 3 quarters.
  • Ellis Investment Partners's Arena Pharmaceuticals Inc position peaked at $96K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Ellis Investment Partners's 13F filing for Q1 2021, filed 3 May 2021.